Cart
sales@molnova.com
KM-023
CAS No. 1097628-00-6
KM-023( —— )
Catalog No. M35996 CAS No. 1097628-00-6
KM-023 is a new second-generation non-nucleoside reverse transcriptase inhibitor for the study of human immunodeficiency virus (HIV) type 1 infection.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 233 | Get Quote |
|
| 5MG | 361 | Get Quote |
|
| 10MG | 542 | Get Quote |
|
| 25MG | 843 | Get Quote |
|
| 50MG | 1150 | Get Quote |
|
| 100MG | 1512 | Get Quote |
|
| 500MG | 3033 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameKM-023
-
NoteResearch use only, not for human use.
-
Brief DescriptionKM-023 is a new second-generation non-nucleoside reverse transcriptase inhibitor for the study of human immunodeficiency virus (HIV) type 1 infection.
-
DescriptionKM-023 is a new second-generation non-nucleoside reverse transcriptase inhibitor for the study of human immunodeficiency virus (HIV) type 1 infection.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV Protease
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1097628-00-6
-
Formula Weight325.36
-
Molecular FormulaC18H19N3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(=O)(C1=C(C(C)C)C(=O)NC(=O)N1CC)C2=CC(C#N)=CC(C)=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
NBD-557
A potent HIV-1 entry inhibitor that blocks the gp120-CD4 interaction; inhibits the fusion between HIV-1NL4-3-luc pseudotyped virus expressing HIV-1HXB2 (X4-tropic) envelope and U87-T4-CXCR4 cells with IC50 of 9.7 uM.
-
Pitstop2
Pitstop2 is a selective inhibitor of amphiphysin association of clathrin terminal domain with an IC50 value of 12 μM. Pitstop2 acutely interferes with receptor-mediated endocytosis, entry of HIV, and synaptic vesicle recycling.
-
Deoxyrhapontin
Desoxyrhaponticin and rhaponticin could be considered as promising fatty acid synthase(FAS) inhibitors, they could inhibit intracellular FAS activity and downregulate FAS expression in human breast cancer MCF-7 cells.
